BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30350856)

  • 21. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
    Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
    Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell translocation gene 2: expression in the rat ovary and potential association with adenine nucleotide translocase 2 in mitochondria.
    Park JI; Kim SG; Baek MW; Park TJ; Lim IK; Seo YW; Chun SY
    Mol Cell Endocrinol; 2013 Mar; 367(1-2):31-40. PubMed ID: 23267836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1.
    Ceccarelli M; Micheli L; D'Andrea G; De Bardi M; Scheijen B; Ciotti M; Leonardi L; Luvisetto S; Tirone F
    Dev Biol; 2015 Dec; 408(1):109-25. PubMed ID: 26524254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence.
    Hwang SS; Lim J; Yu Z; Kong P; Sefik E; Xu H; Harman CCD; Kim LK; Lee GR; Li HB; Flavell RA
    Science; 2020 Mar; 367(6483):1255-1260. PubMed ID: 32165587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions.
    Imran M; Lim IK
    Cell Signal; 2013 Dec; 25(12):2400-12. PubMed ID: 23876794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
    Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
    Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.
    Mao B; Xiao H; Zhang Z; Wang D; Wang G
    Mol Med Rep; 2015 Oct; 12(4):4917-24. PubMed ID: 26151427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
    Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
    Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells.
    Karve TM; Rosen EM
    J Biol Chem; 2012 Sep; 287(37):31503-14. PubMed ID: 22493435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
    Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C676-85. PubMed ID: 22116304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
    Doidge R; Mittal S; Aslam A; Winkler GS
    PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of B‑cell translocation gene 2 on skin cancer cells via the Wnt/β‑catenin signaling pathway.
    Gao SS; Yang XH; Wang M
    Mol Med Rep; 2016 Oct; 14(4):3464-8. PubMed ID: 27510158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.
    Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S
    Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
    Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
    Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BTG2 overexpression increases the radiosensitivity of breast cancer cells in vitro and in vivo.
    Hu X; Xing L; Jiao Y; Xu J; Wang X; Han A; Yu J
    Oncol Res; 2013; 20(10):457-65. PubMed ID: 24308156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.
    Yuniati L; van der Meer LT; Tijchon E; van Ingen Schenau D; van Emst L; Levers M; Palit SA; Rodenbach C; Poelmans G; Hoogerbrugge PM; Shan J; Kilberg MS; Scheijen B; van Leeuwen FN
    Oncotarget; 2016 Jan; 7(3):3128-43. PubMed ID: 26657730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BTG2, its family and its tutor.
    Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
    Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.
    Shen S; Zhang R; Guo Y; Loehrer E; Wei Y; Zhu Y; Yuan Q; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Su L; Chen F; Christiani DC
    Mol Oncol; 2018 Jun; 12(6):913-924. PubMed ID: 29656435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.